FrontLine Genomics.

Digitising Clinical Trials

The era of clinical trials as we know them is quickly coming to an end. Running a trial is expensive and there are commercial risks of failure. As the most critical stage of drug development, the outcomes affect the short and long-term future of the company. Most pharma companies are increasingly turning to digitising the trial process, to increase the sustainability, automate the process and increase patient adherence.

This webinar, organized by FrontLine Genomics focuses on the promise and future directions of digital clinical trials.

Most large scale analysis of clinical trial data only leverages part of the picture. Find out how patient-centric pharma organizations get the full insights to inform their clinical trials process. Jeff Evernham, VP Customer Solutions at Sinequa will show how the unique capabilities of Sinequa's intelligent search platform combines information from multiple data sources to offer your knowledge workers a unified, contextualized view of the information they need. This comprehensive picture of organizational knowledge results in better insights, more effective trials, informed decisions, enhanced compliance, and reduced time to market.

FrontLine Genomics Webinar

Watch the webinar now.

'FrontLine Genomics'

Discover what Sinequa can do for your business.

Let’s have a quick overview of the benefits that our product can give to your company.

Related webinars.

Spread Knowledge to Uncover Legal Risk

Learn how Sinequa helps law firms to uncover risks and maintain a high level of security. And discover the way that Stibbe used our enterprise search solution to gather all their knowledge and documents in a single entry point!

Digi-Tech Pharma & AI 2022

Learn how Sinequa is helping to drive scientific innovation in life sciences and how our intelligent search solution can optimize pharmaceutical industries' scientific search by retrieving data in a unique point of information with this webinar.

©2023 Sinequa. All rights reserved | Privacy policy | Consent choices